News
TRIB
5.49
-5.84%
-0.34
Weekly Report: what happened at TRIB last week (1109-1113)?
Weekly Report · 4d ago
Trinity Biotech Amends Credit Agreement, Note and Warrant Terms
TipRanks · 11/12 22:17
Weekly Report: what happened at TRIB last week (1102-1106)?
Weekly Report · 11/09 09:20
Trinity Biotech trading resumes
TipRanks · 11/05 16:25
Trinity Biotech trading halted, volatility trading pause
TipRanks · 11/05 16:20
Weekly Report: what happened at TRIB last week (1026-1030)?
Weekly Report · 11/02 09:20
Weekly Report: what happened at TRIB last week (1019-1023)?
Weekly Report · 10/26 09:20
Weekly Report: what happened at TRIB last week (1012-1016)?
Weekly Report · 10/19 09:20
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 10/16 21:05
Weekly Report: what happened at TRIB last week (1005-1009)?
Weekly Report · 10/12 09:22
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 10/06 17:05
Trinity Biotech Shareholders Back All Resolutions at September 30 AGM
TipRanks · 10/05 11:49
Weekly Report: what happened at TRIB last week (0928-1002)?
Weekly Report · 10/05 09:21
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 10/02 17:05
Trinity Biotech trading resumes
TipRanks · 10/01 16:20
Trinity Biotech trading halted, volatility trading pause
TipRanks · 10/01 16:15
Weekly Report: what happened at TRIB last week (0921-0925)?
Weekly Report · 09/28 09:20
Weekly Report: what happened at TRIB last week (0914-0918)?
Weekly Report · 09/21 09:20
Weekly Report: what happened at TRIB last week (0907-0911)?
Weekly Report · 09/14 09:21
Trinity Biotech Signs Contract With Red Team Investments For AI Data Center Cooling Solutions
NASDAQ · 09/09 16:11
More
Webull provides a variety of real-time TRIB stock news. You can receive the latest news about Trinity Biotech Plc through multiple platforms. This information may help you make smarter investment decisions.
About TRIB
Trinity Biotech plc is a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemical parameters in serum, plasma and whole blood, and the Company intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Its TrinScreen Human Immunodeficiency Virus (HIV) rapid point-of-care test is a high-quality, single-use immunoassays to aid in the diagnosis of HIV. The Uni-Gold range of rapid point-of-care test devices consist of high-quality, single-use immunoassays to aid in the diagnosis of HIV.